Successful treatment of severe recalcitrant vernal keratoconjunctivitis and atopic dermatitis associated with elevated IgE levels with omalizumab.
Clin Exp Dermatol
; 47(3): 604-606, 2022 Mar.
Article
in En
| MEDLINE
| ID: mdl-34731495
ABSTRACT
We report the clinical case of an atopic patient with important manifestations impacting the quality of life at the cutaneous and ocular site. The condition resisted conventional treatments, and omalizumab had to be used to treat the disease successfully.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Anti-Allergic Agents
/
Dermatitis, Atopic
/
Dermatologic Agents
/
Omalizumab
/
Keratoconjunctivitis
Type of study:
Risk_factors_studies
Aspects:
Patient_preference
Limits:
Adolescent
/
Humans
/
Male
Language:
En
Journal:
Clin Exp Dermatol
Year:
2022
Document type:
Article
Affiliation country: